Cargando…

CXCL12 and CXCR4 as Potential Early Biomarkers for Luminal A and Luminal B Subtypes of Breast Cancer

PURPOSE: Breast cancer is the most common type of malignancy in women. Factors that increase the risk of occurrence include chronic inflammation, with chemokines as its mediators. Therefore, the purpose of the present study was to determine the diagnostic utility of CXCL12 and CXCR4 as modern tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Motyka, Joanna, Gacuta, Ewa, Kicman, Aleksandra, Kulesza, Monika, Malinowski, Paweł, Ławicki, Sławomir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329441/ https://www.ncbi.nlm.nih.gov/pubmed/37426394 http://dx.doi.org/10.2147/CMAR.S416382

Ejemplares similares

Plasma Levels of CXC Motif Chemokine 1 (CXCL1) and Chemokine 8 (CXCL8) as Diagnostic Biomarkers in Luminal A and B Breast Cancer
por: Motyka, Joanna, et al.
Publicado: (2022)

Plasma Levels of Metalloproteinase 3 (MMP-3) and Metalloproteinase 7 (MMP-7) as New Candidates for Tumor Biomarkers in Diagnostic of Breast Cancer Patients
por: Ławicki, Paweł, et al.
Publicado: (2023)

CXC ELR-Positive Chemokines as Diagnostic and Prognostic Markers for Breast Cancer Patients
por: Motyka, Joanna, et al.
Publicado: (2023)

Utility of Matrix Metalloproteinases in the Diagnosis, Monitoring and Prognosis of Ovarian Cancer Patients
por: Kicman, Aleksandra, et al.
Publicado: (2022)

Plasma Levels and Diagnostic Utility of VEGF in a Three-Year Follow-Up of Patients with Breast Cancer
por: Będkowska, Grażyna E., et al.
Publicado: (2021)

CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer Progression
por: Raschioni, Carlotta, et al.
Publicado: (2018)

The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors
por: Ławicki, Sławomir, et al.
Publicado: (2013)

M-CSF in a new biomarker panel with HE4 and CA 125 in the diagnostics of epithelial ovarian cancer patients
por: Będkowska, Grażyna Ewa, et al.
Publicado: (2015)

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

Illuminating luminal B: QSOX1 as a subtype-specific biomarker
por: Das, Padmalaya, et al.
Publicado: (2013)

THE TOTAL LUMINOUS EFFICIENCY OF LUMINOUS BACTERIA
por: Harvey, E. Newton
Publicado: (1925)

Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes
por: Viale, Giuseppe, et al.
Publicado: (2019)

Application of DCE-MRI radiomics signature analysis in differentiating molecular subtypes of luminal and non-luminal breast cancer
por: Huang, Ting, et al.
Publicado: (2023)

MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study
por: Holli-Helenius, Kirsi, et al.
Publicado: (2017)

Enhanced luminance sensitivity on color and luminance pedestals: Threshold measurements and a model of parvocellular luminance processing
por: Shooner, Christopher, et al.
Publicado: (2020)

CXCR7 Functions as a Scavenger for CXCL12 and CXCL11
por: Naumann, Ulrike, et al.
Publicado: (2010)

The luminous and the grey
por: Batchelor, David
Publicado: (2014)

Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype
por: Yanagawa, Masumi, et al.
Publicado: (2012)

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes
por: Maisonneuve, Patrick, et al.
Publicado: (2014)

Identification of a Novel Luminal Molecular Subtype of Breast Cancer
por: Dvorkin-Gheva, Anna, et al.
Publicado: (2014)

Prognostic Value of Lymphangiogenesis Determinants in Luminal and Non-luminal Breast Carcinomas
por: Widodo, Irianiwati, et al.
Publicado: (2018)

DESY: Luminous 1994
Publicado: (1995)

On the theory of the "luminous" electrons
por: Sokolov, A A
Publicado: (1956)

The Administration of Luminal in Epilepsy
Publicado: (1927)

Observations on Luminous Animals
por: Macartney, J.
Publicado: (1811)

Observations on Luminous Animals
por: Macartney, J.
Publicado: (1811)

Observations on Luminous Animals
Publicado: (1811)

Colour, Luminance and Crowding
por: Jennings, BJ, et al.
Publicado: (2013)

The Luminous Fungi of Japan
por: Oba, Yuichi, et al.
Publicado: (2023)

Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer
por: Menikdiwela, Kalhara R., et al.
Publicado: (2022)

Difference between Luminal A and Luminal B Subtypes According to Ki-67, Tumor Size, and Progesterone Receptor Negativity Providing Prognostic Information
por: Inic, Zorka, et al.
Publicado: (2014)

Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis
por: Zajkowska, Monika, et al.
Publicado: (2018)

STUDIES ON LUMINOUS BACTERIA : II. THE INFLUENCE OF TEMPERATURE ON THE INTENSITY OF THE LIGHT OF LUMINOUS BACTERIA.
por: Morrison, Thomas F.
Publicado: (1925)

Low Luminance Visual Acuity and Low Luminance Deficit in Proliferative Diabetic Retinopathy
por: Karatsai, Eleni, et al.
Publicado: (2021)

Plasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers
por: Będkowska, Grażyna Ewa, et al.
Publicado: (2017)

CXCL12/SDF-1 and CXCR4
por: Nagasawa, Takashi
Publicado: (2015)

Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers
por: Sidorkiewicz, Iwona, et al.
Publicado: (2019)

PCA-PAM50 improves consistency between breast cancer intrinsic and clinical subtyping reclassifying a subset of luminal A tumors as luminal B
por: Raj-Kumar, Praveen-Kumar, et al.
Publicado: (2019)

SUN-122 Nuclear PDCD4 Expression Predicts Good Clinical Outcome in Luminal A-Like and Luminal B-Like Breast Cancer Subtypes
por: Madera, Santiago, et al.
Publicado: (2020)

Expression of CXCR4 and CXCL12 and their correlations to the cell proliferation and angiogenesis in mycosis fungoides
por: Maj, Joanna, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gqpcabjglhcotbp15hk8ohul60